passage bio stock price

Passage Bio NASDAQ. PASG shares are trading higher after Raymond James initiated coverage on the stock with an Outperform rating and announced a 29 price target.

Passage Bio Stock Forecast Price News Nasdaq Pasg

The average PASSAGE BIO stock price prediction forecasts a potential upside of 49139 from the current PASG share price of 310.

. RDFN implying a 223 upside. PASG stock quote history news and other vital information to help you with your stock trading and investing. 6 equities research analysts have issued 1-year target prices for Passage Bios shares.

View Passage Bio Inc PASG investment stock information. 10 hours agoThe Goldman Sachs Group lowered shares of Passage Bio from a buy rating to a neutral rating and dropped their price objective for the. PASG stock price quote stock graph news analysis.

Turning to its 52-week. 5 rows Real time Passage Bio Inc. A high-level overview of Passage Bio Inc.

Stock quote and chart Stock Information. Find the latest Passage Bio Inc. On average they anticipate Passage Bios stock price to reach 2000 in the next year.

A The stock price for Passage Bio NASDAQ. Of course Passage Bio may not be the best stock to buy. Their forecasts range from 600 to 3400.

On average Wall Street analysts predict. Is followed by the analysts listed above. Passage Bio was founded by Stephen P.

View Company 289. The firm said the companys gene ther. Passage Bio PASG stock price revenue and financials.

Find out the direct holders institutional holders and mutual fund holders for Passage Bio Inc. 102 rows Discover historical prices for PASG stock on Yahoo Finance. Similarly analyst John Egbert of Stifel has a price target of 36 on Redfin NASDAQ.

The average twelve-month price target for Passage Bio is 2000 with a high price target of 3400 and a low price target of 600. 10 hours agoRaymond James lowered their price objective on Passage Bio from 2900 to 2400 and set an outperform rating on the stock in a research note on Friday March 4th. No competitors data available.

Summary of all time highs changes and price drops for Passage Bio. This suggests a possible upside of 9526 from the stocks current price. Passage Bio market cap is 1718 m.

According to the issued ratings of 6 analysts in the last year the consensus rating for Passage Bio stock is Buy based on the current 2 hold ratings and 4 buy ratings for PASG. Its first product candidate PBGM01 utilizes a AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal beta. Please note that any opinions estimates or forecasts regarding Passage Bio Incs performance made by these analysts are theirs alone and do not represent opinions forecasts or predictions of Passage Bio Inc.

Passage Bio Inc. View Passage Bio stock share price financial statements key ratios and more at Craft. At the very opening of the session the stock price was 191 and reached a high price of 197 prior to closing the session it reached the value of 196.

NASDAQPASG price on Wednesday May 04 rose 1378 above its previous days close as an upside momentum from buyers pushed the stocks value to 223. That PASSAGE BIOs share price could reach 1833 by Mar 8 2023. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.

Get the latest Passage Bio stock price and detailed information including PASG news historical charts and realtime prices. Find real-time PASG - Passage Bio Inc stock quotes company profile news and forecasts from CNN Business. The stock touched a low price of 188Recently in News on Ma.

PASG is 47 last updated Fri Feb 04 2022 210002 GMT0000 Coordinated Universal Time. Current Stock Price for Passage Bio PASG. PASG is priced at 201 after the most recent trading session.

The Company is focused on developing transformative therapies for central nervous system CNS disorders. View daily weekly or monthly. Common Stock PASG Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets.

Squinto Tadataka Yamada. Get the latest Passage Bio Inc PASG detailed stock quotes stock data Real-Time ECN charts stats and more. Is a clinical stage genetic medicines company.

Passage Bio market cap is 1718 m. A look at the stocks price movement the close in the last trading session was 196 moving within a range at 190 and 223.

Passage Bio Stock Worth Keeping An Eye On Nasdaq Pasg Seeking Alpha